Reinhard M. Berner
Expertise in
5
conditions

Reinhard M. Berner

Dresden, SN, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Dresden, SN, DE 

Overview

Reinhard Berner practices practicing medicine in Dresden, Germany.

Mr. Berner is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Streptococcal Group B Infection, Streptococcal Group A Infection, Severe Acute Respiratory Syndrome (SARS), and Strep Throat.

He is actively involved in clinical research, co-authoring 163 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Dresden, SN, Germany
Other Locations
Greifswald, MV, Germany
Berlin, BE, Germany
Freiburg, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

162 Total Publications

Community Health Research im neuen Deutschen Zentrum für Kinder- und Jugendgesundheit (DZKJ)
Community Health Research im neuen Deutschen Zentrum für Kinder- und Jugendgesundheit (DZKJ)
Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Published: August 27, 2026

Frequently Asked Questions about Reinhard M. Berner

Is Reinhard M. Berner a top-rated expert for Streptococcal Group B Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Reinhard M. Berner is classified as an Distinguished expert for Streptococcal Group B Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Reinhard M. Berner participate in research or clinical trials?

Yes. Reinhard M. Berner has published 162 articles and abstracts on conditions like Streptococcal Group B Infection. You can view a list of Reinhard M. Berner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Berner's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile